Provided by Tiger Trade Technology Pte. Ltd.

Tevogen Bio Holdings Inc.

0.0423
0.0000
Post-market: 0.0355-0.0068-16.08%17:52 EST
Volume:6.67K
Turnover:250.64
Market Cap:8.32M
PE:-0.20
High:0.0423
Open:0.0374
Low:0.0373
Close:0.0423
52wk High:0.0891
52wk Low:0.0301
Shares:196.71M
Float Shares:196.71M
Volume Ratio:0.04
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2138
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Aug 27, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 24, 2024

Major Issues Report

Form 8-K - Current report
Aug 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2024

Correspondence

Form CORRESP - Correspondence
Aug 01, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Aug 01, 2024

Correspondence

Form CORRESP - Correspondence
Jul 29, 2024

Correspondence

Form CORRESP - Correspondence
Jul 24, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 24, 2024

Correspondence

Form CORRESP - Correspondence
Jun 21, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 21, 2024

Major Issues Report

Form 8-K - Current report
Jun 12, 2024

Major Issues Report

Form 8-K - Current report
Jun 10, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 31, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
May 29, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 16, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Major Issues Report

Form 8-K - Current report
Apr 29, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Apr 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 26, 2024

Major Issues Report

Form 8-K - Current report